FDA label
What is raltegravir used for?
The FDA-approved uses of raltegravir, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Adult Patients”
Run it in Rivvi
Which 2027 plans near you dropped or restricted raltegravir?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Raltegravir, tablet, film coated
Indications and Usage, quoted from the label by Lupin Pharmaceuticals, Inc. (ANDA217990). Cross-references to other label sections are left out.
Adult Patients
Raltegravir tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in adult patients.
Pediatric Patients
Raltegravir tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients weighing at least 40 kg.
Source: DailyMed label, set id e9661839-bd2e-464f-a6df-6407b4a742b4, version 2, effective October 12, 2026. NDC 70748-327, one of 2 listings for this product.
Questions
What is raltegravir used for?
The FDA label says: “Adult Patients”
What drug class is raltegravir?
FDA lists raltegravir in the Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Raltegravir
- Is Raltegravir a controlled substance?Federal schedule
- Generic for IsentressFDA Orange Book
- Generic for Isentress HdFDA Orange Book
- What is Isentress used for?FDA label uses
- Is Isentress a controlled substance?Federal schedule
- Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors listFDA drug class
- NDC 0006-0227Raltegravir NDC record
- NDC 0006-0473Raltegravir NDC record
- NDC 0006-0477Raltegravir NDC record